Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoid isomerohydrolase (RPE65) is a critical enzyme in the vertebrate visual cycle, primarily expressed in the retinal pigment epithelium (RPE). It catalyzes the conversion of all-trans-retinyl esters to 11-cis-retinol, a vital step in regenerating visual pigments necessary for vision. Mutations in RPE65 cause severe inherited retinal diseases like Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa.
Catalyzes the conversion of all-trans-retinyl esters to 11-cis-retinol, essential for regenerating visual pigments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoid Isomerohydrolase (RPE65).